Browsing by Subject "acute graft rejection"
Now showing items 1-1 of 1
-
A Pilot Randomized Controlled Trial of De Novo Belatacept-based Immunosuppression After Lung Transplantation.
( Wolters Kluwer Health , 2024 , Article)Chronic lung allograft dysfunction (CLAD) is the leading cause of death beyond the first year after lung transplantation. The development of donor-specific antibodies (DSA) is a recognized risk factor for CLAD. Based on ...